Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $598.4650 (-0.91%) ($592.7950 - $610.9900) on Thu. Jun. 4, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.72% (three month average) | RSI | 57 | Latest Price | $598.4650(-0.91%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.7% a day on average for past five trading days. | Weekly Trend | REGN advances 3.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(55%) XLV(45%) SPLV(38%) IVW(37%) IWF(36%) | Factors Impacting REGN price | REGN will decline at least -1.86% in a week (0% probabilities). VIXM(-20%) VXX(-7%) UUP(-6%) TBT(-6%) IYT(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.86% (StdDev 3.72%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $605.87(-1.22%) | 10 Day Moving Average | $584.04(2.47%) | 20 Day Moving Average | $575.72(3.95%) | To recent high | -3.2% | To recent low | 39.7% | Market Cap | $63.454b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |